Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by flow cytometry is associated with NPM1 and FLT3 mutation status in cytogenetically normal acute myeloid leukemia.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Lymphoma, Myeloma & Leukemia

• Publication date

  2012-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clml.2012.01.003PMID 22481022
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutation of FLT3 gene in acute myeloid leukemia with normal cytogenetics and its association with clinical and immunophenotypic features

  2011cited by this paper
• Immunophenotype of acute myeloid leukemia with NPM mutations: prognostic impact of the leukemic compartment size.

  2011cited by this paper
• Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation.

  2011cited by this paper
• Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.

  2010cited by this paper
• BAALC and ERG expression in acute myeloid leukemia with normal karyotype: impact on prognosis

  2010cited by this paper
• Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation

  2009cited by this paper
• Low p14ARF expression in de novo acute myeloid leukemia with normal karyotype is associated with poor survival

  2009cited by this paper
• Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

  2009cited by this paper
• Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis

  2009cited by this paper
• Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications

  2009cited by this paper
• Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogenetics

  2009cited by this paper
• Increased Expression of Macrophage Migration Inhibitory Factor (MIF) Receptor CD74 Is Associated with Inferior Outcome in Younger Patients (Pts) with Cytogenetically Normal Acute Myeloid Leukemia (CN-AML): a Cancer and Leukemia Group B (CALGB) Study.

  2009cited by this paper
• Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.

  2009cited by this paper
• AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features.

  2009cited by this paper
• Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.

  2009cited by this paper
• Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.

  2008cited by this paper
• Age-Dependent Frequencies of NPM-1/FLT3-ITD Mutations in Patients with Normal Karyotype AML

  2008cited by this paper
• Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

  2008cited by this paper
• Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients.

  2008cited by this paper
• Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia

  2008cited by this paper
• Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation.

  2008cited by this paper
• High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated.

  2008cited by this paper
• FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.

  2008cited by this paper
• Molecular characterization of acute myeloid leukemia

  2008cited by this paper
• The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.

  2008cited by this paper
• Analysis of NPM1 Gene Mutations in Chinese Adults with Acute Myeloid Leukemia

  2007cited by this paper
• Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

  2007cited by this paper
• Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study.

  2007cited by this paper
• CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotype.

  2007cited by this paper
• Distinctive expression of myelomonocytic markers and down‐regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation

  2007cited by this paper
• Nucleophosmin gene mutations in acute myeloid leukemia.

  2006cited by this paper
• Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution.

  2006cited by this paper
• FLT3 mutations: biology and treatment.

  2006cited by this paper
• High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations ("cuplike" nuclei).

  2006cited by this paper
• Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

  2005cited by this paper
• Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

  2005cited by this paper
• Analysis of FLT3 internal tandem duplication and D835 mutations in Chinese acute leukemia patients.

  2005cited by this paper
• Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia.

  2005cited by this paper
• Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance.

  2005cited by this paper
• Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.

  2005cited by this paper
• Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.

  2005cited by this paper
• Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia.

  2004cited by this paper
• Prognostic significance of FLT3 mutations in pediatric non-promyelocytic acute myeloid leukemia.

  2004cited by this paper
• A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy.

  2004cited by this paper
• A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication

  2004cited by this paper
• Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria

  2004cited by this paper
• CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.

  2004cited by this paper
• Immunophenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication.

  2003cited by this paper
• Acute Myelogenous Leukemia with t(8;21)—Identification of a Specific Immunophenotype

  2003cited by this paper
• The Expression Pattern of CD56 (N-CAM) in Human Bone Marrow Biopsies Infiltrated by Acute Leukemia

  2003cited by this paper
• Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.

  2002cited by this paper
• Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia.

  2001cited by this paper
• Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene

  2000cited by this paper
• Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

  1999cited by this paper
• Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice.

  1999cited by this paper
• Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia

  1998cited by this paper
• Consed: a graphical tool for sequence finishing.

  1998cited by this paper
• The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.

  1998cited by this paper
• Induction failure in de novo acute myelogenous leukemia is associated with expression of high levels of CD34 antigen by the leukemic blasts.

  1997cited by this paper
• CD7 expression in acute myeloid leukemia.

  1995cited by this paper
• Expression of CD7 on normal human myeloid progenitors.

  1992cited by this paper

• Detection of Cancer Stem Cells in Normal and Dysplastic/Leukemic Human Blood.

  2024cites this paper
• Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia using Flow Cytometry

  2023cites this paper
• Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia using Flow Cytometry.

  2023cites this paper
• Inside the Biology of Acute Leukemias of Ambiguous Lineage: Diagnostic Work-Up, Genomic and Clinical Characterization

  2022cites this paper
• On the distinction between acute leukemia with mutated NPM1 and acute promyelocytic leukemia by flow cytometry

  2022cites this paper
• Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia

  2022cites this paper
• Quantitative analyses of CD7, CD33, CD34, CD56, and CD123 within the FLT3-ITD/NPM1-MUT myeloblastic/monocytic bulk AML blastic populations

  2021cites this paper
• Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment

  2021cites this paper
• Next-generation sequencing reveals gene mutations landscape and clonal evolution in patients with acute myeloid leukemia

  2021cites this paper
• Acute myeloid leukemia with mutated NPM1 mimics acute promyelocytic leukemia presentation

  2020cites this paper
• Morphological and Immunophenotypic Clues to the WHO Categories of Acute Myeloid Leukaemia

  2019cites this paper
• ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML

  2017cites this paper
• Feature genes predicting the FLT3/ITD mutation in acute myeloid leukemia

  2016cites this paper
• Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing

  2016cites this paper
• FLT3 Internal Tandem Duplication Mutation, cMPL and CD34 Expressions Predict Low Survival in Acute Myeloid Leukemia Patients.

  2016cites this paper
• Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia

  2015cites this paper
• Abnormalities of the lymphocyte subsets and their immunophenotype, and their prognostic significance in adult patients with hemophagocytic lymphohistiocytosis

  2015cites this paper
• Deep profiling of multitube flow cytometry data

  2015cites this paper
• Aberrant expression of CD13 identifies a subgroup of standard-risk adult acute lymphoblastic leukemia with inferior survival.

  2014cites this paper
• Automated analysis of single cell leukemia data

  2014cites this paper
• Клинико-гематологическая и молекулярно-генетическая гетерогенность острых миелоидных лейкозов с экспрессией CD7 на бластных клетках

  2013cites this paper